Since its launch in May 2023, Calderys has been participating in HEATERNAL, an EU-funded project working to develop a viable decarbonization solution using thermal energy storage.

The analyst based the rating update on the recent FDA approval of Ojemda (tovorafenib) for BRAF-altered, relapsed, or ...

Vancouver, BC ? ANORTECH INC. ("AnorTech" or the "Company") is pleased to announce the successful completion of the latest phase of its research and development (R&D) program focused on producing ...

JW Therapeutics (HKEx: 2126), an independent and innovative biotechnology company focusing on developing, manufacturing and commercializing cell immunotherapy products, announced that its new ...

Detailed price information for Dell Technologies Inc (DELL-N) from The Globe and Mail including charting and trades.

Scientists at Tomsk Polytechnic University have found out how to improve the properties of new high–entropy (containing at ...

This World Environment Day, we celebrate not only what these companies are doing for the environment, but also how they are ...

As previously announced, the FDA also granted iopofosine I 131 Fast Track Designation and Orphan Drug Designation. The ...

The tech companies in February announced a deal to support iPhones' AI services offering in China, a move likely to help the ...

Researchers sought to determine whether the ALL-Hematotox would be able to predict hematotoxicity for patients with B-ALL who are at risk of severe hematotoxicity following CAR-T therapy.

Discover the major highlights from ASCO 2025, according to researchers and drug developers who attended the convention.